Skip to content
Andrew G. Evans, M.D., Ph.D.

Andrew G. Evans, M.D., Ph.D.

UR Medicine Labs

No ratings currently available, see text in Ratings section below for explanation.

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Not Accepting New Patients

Contact

About Me

Dr. Evans is an Associate Professor of Pathology and Laboratory Medicine, and the Hematopathology Fellowship Program Director. He serves as an attending physician specializing in Hematopathology at Strong Memorial Hospital, and served as a Wilmot Cancer Research Fellow at the Wilmot Cancer Institute...
Dr. Evans is an Associate Professor of Pathology and Laboratory Medicine, and the Hematopathology Fellowship Program Director. He serves as an attending physician specializing in Hematopathology at Strong Memorial Hospital, and served as a Wilmot Cancer Research Fellow at the Wilmot Cancer Institute. He earned his M.D. and Ph.D. degrees from Emory University School of Medicine, and completed his residency and fellowship at Brigham and Women's Hospital, Harvard Medical School, and the Dana Farber Cancer Institute. He is board certified in both Anatomic Pathology and Hematopathology by the American Board of Pathology. Prior to his doctoral studies he earned a bachelor's degree in biology from the University of Chicago, and spent a year doing research at the National Institutes of Health.
Dr. Evans' clinical responsibilities include the diagnostic evaluation of blood, bone marrow, lymph nodes, and other tissues for hematologic and other malignancies. This includes histopathologic and flow cytometric evaluation, along with interpretation of molecular and cytogenetic testing.

Certified Specialties

Hematopathology - American Board of Pathology

Pathology - Anatomic - American Board of Pathology

Faculty Appointments

Associate Professor - Department of Pathology and Laboratory Medicine (SMD)

Credentials

Residency & Fellowship

Fellowship, Hematopathology, Brigham & Womens Hospital. 2012 - 2013

Residency, Pathology, Anatomic Pathology & Clinical Pathology, Brigham & Womens Hospital. 2010 - 2012

Internship, Pathology, Anatomic Pathology & Clinical Pathology, Brigham & Womens Hospital. 2009 - 2010

Education

MD | Emory University School of Medicine. 2009

Awards

Wilmot Cancer Research Fellowship. 2014 - 2017

Medical Scientist Training Program. 2001 - 2008

Post-Baccalaureate Research Training Award. 2000 - 2001

Sigma Xi Scientific Honor Society. 2000

Graduation With Honors. 2000

Howard Hughes Undergraduate Research Fellowship. 1999 - 2000

Research

My current research focuses on the molecular, genetic, and immunologic mechanisms that underlie leukemia and lymphoma development. Specifically, which microenvironmental interactions influence the development and persistence of these diseases. Other interests include the role of chronic viruses in l...
My current research focuses on the molecular, genetic, and immunologic mechanisms that underlie leukemia and lymphoma development. Specifically, which microenvironmental interactions influence the development and persistence of these diseases. Other interests include the role of chronic viruses in lymphoma development, and the genetic characteristics that influence diagnosis and treatment of pre-myeloid leukemias or myelodysplastic syndromes.

Research Lab

URMC Hematopathology Fellowship

Visit Research Lab Website

Publications

Journal Articles

T-Cell-Rich Hodgkin Lymphoma With Features of Classic Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Borderline Category With Overlapping Morphologic and Immunophenotypic Features.

El Hussein S, Fang H, Jelloul FZ, Wang W, Loghavi S, Miranda RN, Friedberg JW, Burack WR, Evans AG, Xu J, Medeiros LJ

Archives of pathology & laboratory medicine.. 2024 August 1148 (8):914-920. Epub 1900 01 01.

In silico predicted compound targeting the IQGAP1-GRD domain selectively inhibits growth of human acute myeloid leukemia.

Sahasrabudhe DM, Liesveld JL, Minhajuddin M, Singh NA, Nath S, Kumar VM, Balys M, Evans AG, Azadniv M, Hansen JN, Becker MW, Sharon A, Thomas VK, Moore RG, Khera MK, Jordan CT, Singh RK

Scientific reports.. 2024 June 414 (1):12868. Epub 06/04/2024.

Gamma-delta T-cell acute lymphoblastic lymphoma/leukemia: a report of a rare entity.

George GV, Kajstura M, Evans AG, Syposs CR

Journal of hematopathology.. 2024 June 17 (2):103-107. Epub 03/25/2024.

ALK-rearranged CD30-positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large-cell lymphoma.

George GV, Wallace DS, Wang Y, Carney J, Elsadawi M, Burack WR, Evans AG, Barr PM, Velez MJ, El Hussein S

Histopathology.. 2024 April 84 (5):900-902. Epub 11/30/2023.

Unicentric Castleman Disease: Illustration of Its Morphologic Spectrum and Review of the Differential Diagnosis.

El Hussein S, Evans AG, Fang H, Wang W, Medeiros LJ

Archives of pathology & laboratory medicine.. 2024 January 1148 (1):99-106. Epub 1900 01 01.

Common clonal origin of three distinct hematopoietic neoplasms in a single patient: B-cell lymphoma, T-cell lymphoma, and polycythemia vera.

Nkosi D, Allbee AW, Rothberg PG, Friedberg JW, Evans AG

Cold Spring Harbor molecular case studies.. 2023 December 9 (4)Epub 01/10/2024.

The role of splenectomy in management of splenic B-cell lymphomas.

Archibald WJ, Baran AM, Williams AM, Salloum RM, Richard Burack W, Evans AG, Syposs CR, Zent CS

Leukemia research.. 2023 May 128 :107053. Epub 03/02/2023.

Clonal cytopenia of undetermined significance (CCUS)-associated reversion of donor-derived, transient ?? T-cell large granular clonal lymphocytosis, emerging post-transplant in a patient with a history of ?? T-cell large granular lymphocytic leukemia.

El Hussein S, Evans AG, Fitzsimmons JM, Leong N, Buldo M, Segal JP, Jajosky AN, Rothberg PG, Liesveld JL, Oltvai ZN

Cold Spring Harbor molecular case studies.. 2023 April 9 (2)Epub 05/09/2023.

Mast cell leukemia morphologic illustration of a rare entity.

Syposs CR, Evans AG, Bennett JM, Liesveld JL, El Hussein S

EJHaem.. 2022 November 3 (4):1422-1424. Epub 09/09/2022.

Nodular Lymphocyte-predominant Hodgkin Lymphoma With Nodular Sclerosis: An Underrecognized Feature Associated With Pattern D.

El Hussein S, Wang X, Fang H, Jelloul FZ, Wang W, Loghavi S, Vega F, Miranda RN, Muzzafar T, Manning JT, Khoury JD, Burack WR, Evans AG, Medeiros LJ

The American journal of surgical pathology.. 2022 September 146 (9):1291-1297. Epub 05/16/2022.

Allogeneic Bone Marrow Transplant as a Cure for Refractory T-Cell Large Granular Lymphocytic Leukemia in an Adolescent.

Fries C, Evans AG, Cheon H, Korones DN, Loughran TP, Andolina JR

Journal of pediatric hematology/oncology.. 2022 August 144 (6):e960-e963. Epub 12/29/2021.

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms.

El Hussein S, Yabe M, Wang W, Pemmaraju N, Loghavi S, Jelloul FZ, Fang H, Medeiros LJ, Burack WR, Evans AG, Liesveld JL, Bennett JM

EJHaem.. 2022 August 3 (3):954-957. Epub 07/03/2022.

Targeted therapy for treatment of patients with classical hairy cell leukemia.

Moore JE, Delibert K, Baran AM, Evans AG, Liesveld JL, Zent CS

Leukemia research.. 2021 March 102 :106522. Epub 02/04/2021.

Hepatic involvement by T-cell neoplasms: a clinicopathologic study of 40 cases.

Li P, Zhang D, Zhou J, Li P, Shen Y, Pan Z, Evans AG, Liao X

Human pathology.. 2020 December 106 :1-12. Epub 09/30/2020.

Multiple B cell malignancies in patients with chronic lymphocytic leukemia: epidemiology, pathology, and clinical implications.

Parikh SA, Meacham PJ, Zent CS, Evans AG

Leukemia & lymphoma.. 2020 May 61 (5):1037-1051. Epub 01/11/2020.

Initial treatment of B-cell prolymphocytic leukemia with ibrutinib.

Moore J, Baran AM, Meacham PJ, Evans AG, Barr PM, Zent CS

American journal of hematology.. 2020 May 95 (5):E108-E110. Epub 01/31/2020.

Incidental splenic findings in pancreatosplenectomy specimens resected for primary pancreatic lesions.

Patel N, Evans AG, Rothberg PG, Gonzalez RS

Histopathology.. 2019 November 75 (5):746-754. Epub 09/05/2019.

Clinical lessons learned from a case of suspected transfusion-transmitted malaria.

Noronha S, Weinberg GA, Sorensen B, Evans AG, Blumberg N

Transfusion.. 2019 March 59 (3):1159. Epub 1900 01 01.

downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels.

Musilova K, Devan J, Cerna K, Seda V, Pavlasova G, Sharma S, Oppelt J, Pytlik R, Prochazka V, Prouzova Z, Trbusek M, Zlamalikova L, Liskova K, Kruzova L, Jarosova M, Mareckova A, Kornauth C, Simonitsch-Klupp I, Schiefer AI, Merkel O, Mocikova H, Burda P, Machova Polakova K, Kren L, Mayer J, Zent CS, Trneny M, Evans AG, Janikova A, Mraz M

Blood.. 2018 November 29132 (22):2389-2400. Epub 09/13/2018.

Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells.

Geyer MB, Manjunath SH, Evans AG, Park JH, Davila ML, Cutler CS, Wang X, Wang Y, Senechal B, Rivière I, Sadelain M, Liesveld JL, Brentjens RJ

Leukemia & lymphoma.. 2018 July 59 (7):1717-1721. Epub 10/18/2017.

Loss of Full-Length GATA1 Expression in Megakaryocytes Is a Sensitive and Specific Immunohistochemical Marker for the Diagnosis of Myeloid Proliferative Disorder Related to Down Syndrome.

Lee WY, Weinberg OK, Evans AG, Pinkus GS

American journal of clinical pathology.. 2018 March 7149 (4):300-309. Epub 1900 01 01.

Novel 1.3 Mb germline duplication in chromosome 8q21 by microarray comparative genomic hybridization plus single nucleotide polymorphism analysis in an adult patient with pancytopenia and urinary bladder complications

Reyes-Barron C; Evans AG; Miyamoto H; Zhang B; Iqbal MA.

Clinical Case Reports. 2018; 6(10): 1947-1952.

Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era.

Hunter BD, Herr M, Meacham PJ, Barlaskar F, Evans AG, Burack WR, Liesveld JL, Becker MW, Milner LA, Constine LS, Dhakal S, Barr PM, Friedberg JW, Casulo C

Clinical lymphoma, myeloma & leukemia.. 2017 March 17 (3):145-151. Epub 11/23/2016.

Green Inclusions in Neutrophils and Monocytes Are an Indicator of Acute Liver Injury and High Mortality.

Patel N, Hoffman CM, Goldman BI, Bentley K, Burack WR, Evans AG

Acta haematologica.. 2017 138 (2):85-90. Epub 08/17/2017.

Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance.

Evans AG, Ahmad A, Burack WR, Iqbal MA

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.. 2016 October 29 (10):1183-99. Epub 07/08/2016.

Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.

Balderman SR, Li AJ, Hoffman CM, Frisch BJ, Goodman AN, LaMere MW, Georger MA, Evans AG, Liesveld JL, Becker MW, Calvi LM

Blood.. 2016 February 4127 (5):616-25. Epub 12/04/2015.

Spontaneous Remission in an Older Patient with Relapsed FLT3 ITD Mutant AML.

Vachhani P; Medler JH; Evans AG; Deeb G; Starostik P, Wallace PK; Wang ES.

Case Reports in Hematology. 2016; .

Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells.

Evans AG, Rothberg PG, Burack WR, Huntington SF, Porter DL, Friedberg JW, Liesveld JL

British journal of haematology.. 2015 October 171 (2):205-209. Epub 06/18/2015.

Notch signaling in the malignant bone marrow microenvironment: implications for a niche-based model of oncogenesis.

Evans AG, Calvi LM

Annals of the New York Academy of Sciences.. 2015 January 1335 (1):63-77. Epub 10/28/2014.

The absence of M1 leads to increased establishment of murine gammaherpesvirus 68 latency in IgD-negative B cells.

Krug LT, Evans AG, Gargano LM, Paden CR, Speck SH

Journal of virology.. 2013 March 87 (6):3597-604. Epub 01/09/2013.

Clinicopathologic features and long-term outcomes of NUT midline carcinoma.

Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, Lüer SC, Muhammed S, Evans AG, Sholl LM, Rosai J, Giraldi E, Oakley RP, Rodriguez-Galindo C, London WB, Sallan SE, Bradner JE, French CA

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2012 October 1518 (20):5773-9. Epub 08/15/2012.

Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.

Evans AG, French CA, Cameron MJ, Fletcher CD, Jackman DM, Lathan CS, Sholl LM

The American journal of surgical pathology.. 2012 August 36 (8):1222-7. Epub 1900 01 01.

A gammaherpesvirus-secreted activator of Vbeta4+ CD8+ T cells regulates chronic infection and immunopathology.

Evans AG, Moser JM, Krug LT, Pozharskaya V, Mora AL, Speck SH

The Journal of experimental medicine.. 2008 March 17205 (3):669-84. Epub 03/10/2008.

Expansion of effector memory TCR Vbeta4+ CD8+ T cells is associated with latent infection-mediated resistance to transplantation tolerance.

Stapler D, Lee ED, Selvaraj SA, Evans AG, Kean LS, Speck SH, Larsen CP, Gangappa S

The Journal of immunology : official journal of the American Association of Immunologists.. 2008 March 1180 (5):3190-200. Epub 1900 01 01.

The M4 gene of gammaHV68 encodes a secreted glycoprotein and is required for the efficient establishment of splenic latency.

Evans AG, Moorman NJ, Willer DO, Speck SH

Virology.. 2006 January 20344 (2):520-31. Epub 09/26/2005.

A SICAvar switching event in Plasmodium knowlesi is associated with the DNA rearrangement of conserved 3' non-coding sequences.

Corredor V, Meyer EV, Lapp S, Corredor-Medina C, Huber CS, Evans AG, Barnwell JW, Galinski MR

Molecular and biochemical parasitology.. 2004 November 138 (1):37-49. Epub 1900 01 01.

Coevolutionary genetics of Plasmodium malaria parasites and their human hosts.

Evans AG, Wellems TE

Integrative and comparative biology.. 2002 April 42 (2):401-7. Epub 1900 01 01.

Near-Tetraploid Acute Myeloid Leukemia with Extensive Erythrophagocytosis. Case-of-the-Quarter, Fall/Winter 2014. Society for Hematopathology/European Association for Hematopathology, (http://www.sh-eahp.org/knowledge-center/case-of-the-quarter)

Evans AG; Loo A; Burack WR.

.

Books

Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver (2020)

Chapter: Infectious and Inflammatory Mimics of Hematopoietic Disorders in Liver and Spleen

Authors: Gonzalez, R., and Evans, A.G.

Publisher: Springer International Publishing 2020

Practical Breast Pathology: Frequently Asked Questions (2019)

Chapter: Mesenchymal and Lymphoid Lesions of the Breast

Authors: Wang, X., and Evans, A.G.

Publisher: Springer International Publishing 2019

Flow Cytometry: Approaches, Principles and Applications (2019)

Chapter: Flow Cytometry Immunophenotyping of Plasma Cells & Plasma Cell Neoplasms

Authors: Evans, A.G.

Publisher: Nova Science Publishers, Hauppauge, NY. 2019

Textbook of Uncommon Cancer, 5th Edition (2017)

Chapter: Rare B Cell Lymphoproliferative Disorders

Authors: Andrew G. Evans and Paul M. Barr

Publisher: Wiley Blackwell 2017

Williams Hematology, 9th Edition (2015)

Chapter: Burkitt Lymphoma

Authors: Andrew G. Evans and Jonathan W. Friedberg

Publisher: McGraw-Hill 2015

Hematopathology: High Yield Pathology Series (2013)

Chapter: Reactive Lymphadenopathies, Infectious and Non-infectious

Authors: Andrew G. Evans and Olga Pozdnyakova

Publisher: Elsevier Saunders 2013

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.